Evommune EVMN
NYSE EVMN
$8.64 +0.80 (+10.14%)
As of: Nov 11, 2026 · 3:59 PM EST

Evommune (EVMN) Market Capitalization (2025 - 2026)

Updated

Evommune (EVMN) posted Market Capitalization of $482.18 million for Q2 2026, down 41.8% from the prior quarter.

Analysis

Evommune (EVMN) Market Capitalization (2025 - 2026) Analysis & Trends

For FY2025, Evommune's Market Capitalization came in at $105.06 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Evommune 285.17 Mn -352.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 482.18 Mn
Mar 31, 2026 828.06 Mn
Dec 31, 2025 105.06 Mn
API Access

Evommune Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=EVMN&period=max&api_key=YOUR_API_KEY